Skip to main navigation
Skip to search
Skip to main content
PubliRES - Publications, Research, Expertise and Skills Home
Italiano
English
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Luca Miele
Department of Medicine and Translational Surgery
Faculty of Medicine and Surgery
Academic Field: General Clinical Medicine
Research output
:
Contribution to journal
›
Article
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Liver Fibrosis
100%
Randomized Controlled Trial
100%
Placebo
100%
Fibrosis
54%
Nonalcoholic Fatty Liver Disease Activity Score
27%
Therapeutic Procedure
18%
Diseases
9%
Adverse Event
9%
Nausea
9%
Liver Disease
9%
Biopsy
9%
Low Density Lipoprotein Cholesterol
9%
Liver Cirrhosis
9%
Thyroid Hormone Receptor Beta
9%
Diarrhea
9%
Group Trial
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Fibrosis
100%
Disease Activity Score
27%
Thyroid Hormone Receptor Beta
9%